| Business Summary | | Datascope
Corporation
is
a
diversified
medical
device
company
that
manufactures
and
markets
proprietary
products
for
clinical
health
care
markets
in
interventional
cardiology
and
radiology,
cardiovascular
and
vascular
surgery,
anesthesiology,
emergency
medicine
and
critical
care.
The
Company
is
a
pioneer
in
intra-aortic
balloon
pumping,
or
cardiac
assist
systems,
and
also
manufactures
and
markets
a
broad
line
of
physiological
monitors
designed
to
provide
for
patient
safety
and
management
of
patient
care.
The
Company's
vascular
sealing
products
have
revolutionized
the
technology
that
is
used
to
seal
arterial
punctures
to
stop
bleeding
after
catheterization
procedures.
The
Company's
InterVascular,
Inc.
subsidiary
manufactures
and
distributes
a
proprietary
line
of
knitted
and
woven
polyester
vascular
grafts
and
patches
for
reconstructive
vascular
and
cardiovascular
surgery,
while
it
is
also
involved
in
the
life
science
research
market
through
its
newly
formed
subsidiary,
Genisphere,
Inc. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Datascope
Corporation
manufactures
proprietary
products
for
interventional
cardiology,
anesthesiology,
cardiovascular
and
vascular
surgery.
For
the
fiscal
year
ended
6/30/01,
revenues
rose
4%
to
$312.8
million.
Net
income
rose
4%
to
$34.2
million.
Revenues
reflect
higher
patient
monitoring
sales
and
increased
international
demand
for
InterGard(R)
Silver.
Higher
income
was
partially
offset
by
the
absence
of
a
$3.8
million
gain
on
the
sale
of
technology. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Lawrence Saper, 72 Chairman,
and CEO | $4.6M | $1.9M | Murray Pitkowsky, 69 Sr.
VP, Sec. | 377K | 272K | Leonard Goodman, 56 VP,
CFO and Treasurer | 427K | -- | S. Arieh Zak, 39 VP
- Regulatory Affairs and Corp. Counsel | 363K | 40K | James Cooper, 49 VP
of HR | -- | -- | Dollar
amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|